Porphyria-like Neurological Crises and Fanconi Syndrome-Type Renal Tubular Disorder in An Undiagnosed Case of Chronic Tyrosinemia Type ۱: A Case Report and Review of the Literature

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 18

فایل این مقاله در 19 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_INJPM-14-8_006

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Background: Tyrosinemia type ۱ (TYRSN۱) is an autosomal recessive metabolic disease that occurs due to a defect in the enzyme fumarylacetoacetate hydroxylase. In the case of a defect in this enzyme, toxic metabolites resulting from the breakdown of tyrosine accumulate in vital organs, leading to various symptoms and problems in these patients.Case Presentation: A ۳-year-old boy was admitted to the hospital with confusion, constipation, vomiting, abdominal pain, fever, oliguria, and anorexia. On examination, hypertension, genu varum, abnormal gait, and urinary retention were observed. Laboratory tests revealed hypoglycemia, glucosuria, metabolic acidosis, anemia, hypokalemia, and hypocalcemia. Ultrasound and CT scans revealed large kidneys and a heterogeneous liver, with multiple nodules. Additional tests revealed elevated alkaline phosphatase, a high alpha-fetoprotein level, hypophosphatemia, and increased urinary excretion of phosphorus and potassium. Hand radiography also revealed rickets. Due to suspicion of hereditary diseases of amino acid metabolism, blood and urine chromatography revealed a marked accumulation of tyrosine. The diagnosis of chronic TYRSN۱ was confirmed by measuring high urinary excretion of succinylacetone. The patient was treated with nitisinone and a restricted diet of tyrosine and phenylalanine, and within ۱ week, he showed a dramatic response to treatment.Conclusion: Our patient was a case of chronic TYRSN۱ who, owing to a lack of timely diagnosis, had symptoms of neurological crises similar to acute porphyria, as well as symptoms of Fanconi syndrome-type renal tubular disorder and rickets. Due to the rarity of this disease and its diverse clinical manifestations, its diagnosis is challenging in countries such as Iran, where screening for this disease is not routinely

نویسندگان

- -

Cancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.

- -

Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.

- -

Students Research Committee, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.

- -

Pediatric Department of Bou Ali Hospital, Ardabil University of Medical Sciences, Ardabil, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Scott CR. The genetic tyrosinemias. InAmerican Journal of Medical Genetics ...
  • Cassiman D, Zeevaert R, Holme E, Kvittingen EA, Jaeken J. ...
  • Lindblad B, Lindstedt S, Steen GO. On the enzymic defects ...
  • Chen J, Sun J, Li X, Du M. Identification and ...
  • Angileri F, Bergeron A, Morrow G, Lettre F, Gray G, ...
  • Chinsky JM, Singh R, Ficicioglu C, Van Karnebeek CD, Grompe ...
  • Rokaitė R, Čibirkaitė A, Zeleckytė V, Lazdinytė G, Dženkaitis M. ...
  • Morrow G, Tanguay RM. Biochemical and clinical aspects of hereditary ...
  • Grompe M, Al-Dhalimy M, Finegold M, Ou CN, Burlingame T, ...
  • King LS, Trahms C, Scott CR. Tyrosinemia type I. InGeneReviews®[Internet] ...
  • González-Lamuño D, Sánchez-Pintos P, Andrade F, Couce ML, Aldámiz-Echevarría L. ...
  • Van Spronsen FJ, Thomasse Y, Smit GP, Leonard JV, Clayton ...
  • De Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell ...
  • Kawabata K, Kido J, Yoshida T, Matsumoto S, Nakamura K. ...
  • Prabhakar S, Banu N, Srinivas M. Tyrosinemia type ۱: A ...
  • Thomas H, Carlisle RC. Progress in gene therapy for hereditary ...
  • Mitchell G, Larochelle J, Lambert M, Michaud J, Grenier A, ...
  • Dawson C, Ramachandran R, Safdar S, Murphy E, Swayne O, ...
  • Önenli Mungan N, Yıldızdaş D, Kör D, Horoz ÖÖ, İncecik ...
  • van Ginkel WG, Jahja R, Huijbregts SC, van Spronsen FJ. ...
  • Larochelle J, Alvarez F, Bussières JF, Chevalier I, Dallaire L, ...
  • Sun MS, Hattori S, Kubo S, Awata H, Matsuda I, ...
  • van Ginkel WG, van Vliet D, van Der Goot E, ...
  • Forget S, Patriquin HB, Dubois J, Lafortune M, Merouani A, ...
  • van Ginkel WG, Rodenburg IL, Harding CO, Hollak CE, Heiner-Fokkema ...
  • Ilyaz M, Jadhav RS, Pande V, Mane S, Mokkarala P. ...
  • Paradis K, D'Angata ID, Bijleveld C, Bueller H, Taminiau J, ...
  • Croffie JM, Gupta SK, Chong SK, Fitzgerald JF. Tyrosinemia type ...
  • Herbst DA, Reddy KR. Risk factors for hepatocellular carcinoma. Clinical ...
  • Matpathi A. A rare case report of tyrosinemia type I. ...
  • Lindstedt MS, Holme ME, Lock PE, Hjalmarson MO, Strandvik MB. ...
  • Introne WJ. Nitisinone: Two decades treating hereditary tyrosinaemia type ۱. ...
  • Aharbil F, Jarti M, Nacir O, Lairani F, Ait Errami ...
  • Schlune A, Thimm E, Herebian D, Spiekerkoetter U. Single dose ...
  • Mayorandan S, Meyer U, Gokcay G, Segarra NG, de Baulny ...
  • Äärelä L, Hiltunen P, Soini T, Vuorela N, Huhtala H, ...
  • van Ginkel WG, Jahja R, Huijbregts SC, Daly A, MacDonald ...
  • García MI, de la Parra A, Arias C, Arredondo M, ...
  • Bendadi F, De Koning TJ, Visser G, Prinsen HC, De ...
  • Malik S, NiMhurchadha S, Jackson C, Eliasson L, Weinman J, ...
  • Yue TA, Yuanyuan KO. Hereditary tyrosinemia type Ⅰ: newborn screening, ...
  • Bartlett DC, Lloyd C, McKiernan PJ, Newsome PN. Early nitisinone ...
  • نمایش کامل مراجع